Fingerprint
Dive into the research topics of 'Gemtuzumab ozogamicin with fludarabine, cytarabine, and granulocyte colony stimulating factor (FLAG-GO) as front-line regimen in patients with core binding factor acute myelogenous leukemia'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically